Search

Search Constraints

You searched for: Author/Creator Guclu, S.

Search Results

3. Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders. (February 2017)